Tokyo rebounded in the week ended December 1. The Nikkei 225 advanced 6.1%, to close at the 8,300 mark, while the Topix index rose 3.1%. The market's comeback was helped by a respite in the volatility of overseas stock markets, as well as reports of economic stimulus measures being planned or taken by major countries, including a massive 200.0-billion euro ($252.28 billion) package announced by the European Union. Meanwhile, Japanese investors were discouraged by the lack of speed from local politicians who failed to pass a second supplementary budget to finance economic stimulus programs and proposed legislature to make the government inject capital into financial institutions. The pharmaceutical index edged up 0.8%, underperforming the market.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze